Small Molecules for Imaging
Total Trials
57
As Lead Sponsor
27
As Collaborator
30
Total Enrollment
4,332,862
NCT00162344
A Study of Stress Heart Imaging in Patients With Diabetes at Risk for Coronary Disease.
Phase: Phase 4
Role: Lead Sponsor
Start: Dec 31, 2003
Completion: Dec 31, 2005
NCT00162058
A Phase II Study of DMP 115 to Assess Focal Liver Lesions
Phase: Phase 2
Start: Mar 31, 2004
Completion: Apr 30, 2006
NCT00162357
Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by Angioplasty
Start: Apr 30, 2004
NCT00162370
A Study of Stress Echocardiography in Post-Menopausal Women at Risk for Coronary Disease
Completion: Oct 31, 2012
NCT00162045
A Trial to Determine Radiation Exposure to Organs and Assess the Safety of CARDIOLITE® in Pediatric Subjects
Phase: Phase 1/2
Start: Jan 31, 2005
Completion: Jun 30, 2007
NCT00162331
CARDIOLITE-413: A Study for Patients Who Had a PCI for an Acute MI
Completion: Jul 31, 2007
NCT00162032
A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease
Phase: Phase 3
Start: Aug 31, 2005
Completion: Dec 31, 2010
NCT00401687
DMP115 in Patients With an Ejection Fraction Between 25%-40% to Evaluate the Use of Contrast Echocardiography to Assess Heart Function
Start: Jul 31, 2006
Completion: Apr 30, 2008
NCT00539045
Diagnostic Utility of Contrast Echocardiography for Detection of LV Thrombi Post ST Elevation Myocardial Infarction
Phase: N/A
Role: Collaborator
Start: Mar 31, 2007
Completion: Jan 31, 2015
NCT00707499
A Phase I Study in Healthy Volunteers to Assess Safety of BMS747158
Phase: Phase 1
Start: Sep 30, 2007
Completion: Jun 30, 2008
NCT01005212
Evaluation of Contrast-Enhanced Ultrasound to Detect Endoleaks After Endovascular Aortic Aneurysm Repair
Start: Jan 31, 2008
Completion: Sep 30, 2010
NCT00625365
A Prospective, Phase IV, Surveillance Registry Study to Evaluate the Safety of DEFINITY® in Clinical Practice
Start: Feb 29, 2008
Completion: Jul 31, 2009
NCT00707538
A Phase I Study in Healthy Volunteers to Assess Dosimetry and Safety Following Injection of BMS747158 at Stress
Start: Jun 30, 2008
Completion: Oct 31, 2008
NCT01299649
Retrospective Safety Study to Compare Mortality in Intensive Care Unite (ICU) Patients Undergoing Echocardiography With or Without DEFINITY®
Completion: Dec 31, 2008
NCT00849108
Development of 1-Day Rest/Stress Cardiac PET Perfusion Imaging Protocol of BMS747158
Start: Jan 31, 2009
Completion: Jun 30, 2010
NCT01436773
Identification of Carotid Vasa Vasorum and Correlation With Acute Coronary Events
Start: May 31, 2009
Completion: May 31, 2012
NCT00930631
Study of [3H] BMS747158 in Healthy Male Subjects
Start: Jun 30, 2009
Completion: Jan 31, 2010
NCT00918866
A Study of Commercial DEFINITY® to Monitor the Effects of the Heart's Pulmonary Artery Pressure
Start: Jul 31, 2009
Completion: Dec 31, 2009
NCT00891241
A Phase 1 Trial to Determine Dosimetry, Biodistribution and Safety of LMI 1195-101 in Healthy Subjects and Patients With Heart Failure
Start: Aug 31, 2009
Completion: Nov 30, 2009
NCT01151566
Can Ultrasound Replace Computed Tomography (CT) Scan in Those Unable to Have Computed Tomography (CT) Contrast Agents
Start: Sep 30, 2009
Completion: Dec 31, 2013
NCT01135316
Prospective Evaluation of the Incidence of NSF in Patients With Kidney Disease Undergoing MR
Start: Oct 31, 2009
Completion: Sep 30, 2013
NCT01062178
Efficacy of Ultrasound Contrast Agent to Assess Renal Masses
Completion: Dec 31, 2012
NCT01021865
Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes
Start: Feb 28, 2010
Completion: Jul 31, 2014
NCT01085175
Trial to Determine Imaging Parameters of LMI1195 in Heart Failure Patients at Low and High Risk of Defibrillator Firing
Start: May 31, 2010
Completion: Feb 28, 2011
NCT01347710
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Start: Jun 30, 2011
NCT01165892
Pulmonary MR Angiography and Lower Extremity MR Venous Imaging Using Gadofosveset (Ablavar)
Start: Jul 31, 2011
Completion: Apr 30, 2013
NCT01384591
Pilot Study of Losartan and N-acetylcysteine as Inhibitors of Muscle Oxidative Stress in Elderly
Completion: May 31, 2015
NCT01431300
Dose-varied Evaluation of Ablavar-enhanced MR Angiography of the Central Veins of the Chest in Healthy Participants
Start: Aug 31, 2011
Completion: Jul 31, 2013
NCT01490892
Quantitative Subharmonic Breast Imaging
Start: Nov 30, 2011
Completion: Apr 5, 2019
NCT01681524
Open Label Study to Access Flurpiridaz F18 in PET MPI Verses SPECT MPI
Start: Nov 30, 2012
Completion: May 31, 2014
NCT01085162
A Long-term Follow-up Study to Evaluate the Predictive Value of BMS747158 in Patients Suspected of Coronary Artery Disease (CAD)
Start: Mar 31, 2013
Completion: Mar 31, 2015
NCT02086695
Early Detection of Broken Hearts in Cancer Patients
Start: Jun 30, 2013
Completion: Sep 30, 2015
NCT04093973
Bicycle Exercise Echocardiography to Assess Physiological Significance of Mitral Annular Calcification
Start: Nov 7, 2014
Completion: Jun 30, 2022
NCT03674255
Echocardiography: Value and Accuracy at REst and STress
Start: Mar 31, 2015
Completion: Jan 31, 2032
NCT02764801
Contrast-enhanced Ultrasound Evaluation of Chemoembolization
Start: Apr 30, 2016
Completion: Feb 1, 2023
NCT03466255
Early Detection of Cardiovascular Disease
Start: Dec 6, 2016
Completion: Jan 11, 2022
NCT03243942
Noninvasive, Subharmonic Intra-Cardiac Pressure Measurement
Start: Jun 1, 2017
Completion: Jun 26, 2019
NCT03297112
Contrast-Enhanced Subharmonic Ultrasound Imaging in Improving Characterization of Adnexal Masses in Patients Undergoing Surgery
Phase: Early Phase 1
Start: Aug 1, 2017
Completion: Sep 4, 2018
NCT03196076
Contrast-enhanced Ultrasound for Complex Kidney Lesion Diagnosis in Patients With CKD Extension
Start: Aug 28, 2017
Completion: Mar 19, 2021
NCT03173716
Real-Time Myocardial Perfusion Echocardiography in the ICU
Start: Sep 28, 2017
Completion: Dec 31, 2019
NCT03493516
Prediction of ARrhythmic Events With Positron Emission Tomography II
Start: Apr 8, 2018
Completion: Dec 31, 2025
NCT03571672
DEF-314 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY
Start: Oct 24, 2018
Completion: Aug 30, 2019
NCT03719612
DEF-315 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY
Start: Dec 28, 2018
Completion: Jan 9, 2020
NCT03907657
Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau
Start: Sep 23, 2019
Completion: Mar 13, 2023
NCT04286100
Contrast Specific Echocardiogram Versus Left Ventricular Opacification (LVO) Imaging Settings
Start: Apr 29, 2020
Completion: Mar 31, 2026
NCT05247541
Diagnosing Compartment Syndrome With SHAPE vs Elastography
Phase: Phase 2/3
Start: Jul 1, 2020
Completion: Dec 1, 2023
NCT04557501
PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer
Start: Jan 6, 2021
Completion: Jan 31, 2029
NCT05416385
Carotid Intraplaque Neovascularization Combined With Stress Echo
Start: Aug 16, 2021
Completion: Aug 16, 2026
NCT05394259
A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer
Start: Oct 28, 2022
Completion: Feb 2, 2027
NCT05712473
An Observational Registry Assessing the Impact of PYLARIFY® (Piflufolastat F18) PET in Patients With Prostate Cancer
Start: Feb 28, 2023
Completion: Jun 30, 2029
NCT05820724
PSMA PET Scan and mpMRI for Prostate Cancer Detection
Start: May 1, 2023
Completion: May 1, 2026
NCT06074510
PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer
Start: Feb 8, 2024
Completion: Sep 30, 2026
NCT05160480
A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG
Start: Jun 7, 2024
Completion: Mar 1, 2026
NCT06298916
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
Start: Aug 31, 2025
Completion: Apr 30, 2026
NCT06361810
PSMA Therapy and Immunotherapy in Kidney Cancer
Start: Oct 1, 2025
NCT07084909
Piflufolastat F 18 PET/CT in Patients With Suspected, or at High Risk for Metastatic ccRCC
Start: Oct 31, 2025
Completion: Sep 30, 2027
Loading map...